Emerging and Re-emerging Infectious Diseases: Recent Developments on Therapeutics, Clinical Epidemiology and Transmission
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: closed (15 November 2023) | Viewed by 1762
Special Issue Editors
Interests: virology; molecular biology; virus–host interactions; antivirals; antibodies; vector competence
Interests: virology; biochemistry; enzymology; molecular biology; pharmacology
Special Issue Information
Dear Colleagues,
In the modern age, ease of cross-border travelling has become a potent driving force in the emergence and global spread of infectious diseases. In addition to constant viral evolution and adaptation, human and ecological factors, such as the breakdown of public health measures and climate change, have contributed to the emergence and re-emergence of infectious diseases. Hence, the sustained flow of new information is necessary in order to complement and cope with the perpetual challenges caused by these infections. This Special Issue aims to highlight recent scientific and technical developments in novel and improved therapeutic agents and inhibitors, as well as the latest epidemiological data on different emerging and re-emerging infectious diseases. Moreover, we are interested in research outputs on underlying epigenetics and immunologic pathways that may regulate or enhance the transmission and pathogenesis of the involved agents. We welcome original research articles, reviews and case reports based on authors’ research findings and expertise. Our goal is to provide extensive coverage of high-quality research and comprehensive reviews, which we hope will contribute considerably to existing research and benefit the medical community.
Dr. Yee Tsuey Ong
Dr. Adrian Oo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infectious disease
- antiviral
- antimicrobial
- therapeutic delivery system
- epidemiology
- transmission
- host factors
- epigenetics
- immunology
- risk factors
